BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4641855)

  • 1. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.
    Goetzl EJ; Austen KF
    J Exp Med; 1972 Dec; 136(6):1564-80. PubMed ID: 4641855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility.
    Goetzl EJ; Gigli I; Wasserman S; Austen KF
    J Immunol; 1973 Sep; 111(3):938-45. PubMed ID: 4741302
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-dependent generation of chemotactic activity in serum.
    Weksler BB; Coupal CE
    J Exp Med; 1973 Jun; 137(6):1419-30. PubMed ID: 4709268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dialyzable leukocyte extracts (DLEs) with transfer factor activity on leukocyte migration in vitro. III. Characterization of the antigen-independent migration inhibition factor in DLEs as a neutrophil immobilizing factor.
    Wilson GB; Smith CL; Fudenberg HH
    J Allergy Clin Immunol; 1979 Jul; 64(1):56-66. PubMed ID: 447952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid.
    Goetzl EJ; Wasserman SI; Gigli I; Austen KF
    J Clin Invest; 1974 Mar; 53(3):813-8. PubMed ID: 4273024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
    Snyderman R; Gewurz H; Mergenhagen SE
    J Exp Med; 1968 Aug; 128(2):259-75. PubMed ID: 4873021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil chemotactic activity released in supernatants of human leukocytes challenged with antigens or anti-human IgE.
    Akiyama K; Pruzansky JJ; Ricketti AJ; Greenberger PA; Patterson R
    J Lab Clin Med; 1984 Sep; 104(3):391-403. PubMed ID: 6470565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal chemotactic migration of polymorphonuclear leukocytes stimulated with mononuclear-derived chemotactic factor in ulcerative colitis.
    Hermanowicz A; Nawarska Z
    Int Arch Allergy Appl Immunol; 1986; 81(1):63-8. PubMed ID: 3744579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique complement derived chemotactic factor for tumor cells.
    Romualdez AG; Ward PA
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4128-32. PubMed ID: 172896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for assessing the in vitro chemotactic response of neutrophils utilizing 51cr-labeled human leukocytes.
    Goetzl EJ; Austen KF
    Immunol Commun; 1972; 1(5):421-30. PubMed ID: 4217768
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    Becker EL
    J Exp Med; 1972 Feb; 135(2):376-87. PubMed ID: 4551218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the regulation of the neutrophil chemotactic response using a rapid and reliable method for measuring random migration and chemotaxis of neutrophil granulocytes.
    Keller HU; Gerber H; Hess MW; Cottier H
    Agents Actions; 1976 Feb; 6(1-3):326-39. PubMed ID: 782208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity.
    Goetzl EJ; Wasserman SI; Austen F
    Arch Pathol; 1975 Jan; 99(1):1-4. PubMed ID: 234219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte and neutrophil chemotactic activity of normal and diluted human serum and plasma.
    Jungi TW
    Int Arch Allergy Appl Immunol; 1977; 53(1):18-28. PubMed ID: 838512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.
    Wiggins RC; Giclas PC; Henson PM
    J Exp Med; 1981 Jun; 153(6):1391-404. PubMed ID: 6910482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic activity of human blood leukocytes in plasma treated with EDTA: chemoattraction of neutrophils about monocytes is mediated by the generation of NAP-2.
    Malawista SE; Van Damme J; Smallwood JI; de Boisfleury Chevance A
    J Leukoc Biol; 2002 Jul; 72(1):175-82. PubMed ID: 12101278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin-induced production of a monocyte chemotactic factor by human peripheral blood leukocytes.
    Foon KA; Wahl SM; Oppenheim JJ; Rosenstreich DL
    J Immunol; 1976 Nov; 117(5 Pt 1):1545-52. PubMed ID: 1002988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.